Bo Ying
Chief Executive Officer Abogen Bioscience
Dr. Bo Ying is the founder and CEO of Abogen Biosciences, the leading mRNA company in China focused on developing innovative mRNA technologies for prophylactic vaccines, cancer and autoimmune diseases. Dr. Ying has many years of experiences in the development of nucleic acid-based therapeutics, and he has held various roles in leading biopharmaceutical companies in Boston. His work has been published in journals such as Cell, Lancet Microbe, Cell Research, and he is also the inventor of over 100 patents and patent applications.
Seminars
Wednesday 11th November 2026
Exploring the Technical & Clinical Progress of TCE/in Vivo CART
11:30 am
- Presenting an overview of Abogen’s mRNA and LNP platform
- Showcasing clinical progress of TCE/in vivo CART
- Sharing future perspectives of mRNA therapeutics
